Ovarian Carcinoma
- 1 November 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 121 (11) , 1262-1264
- https://doi.org/10.1001/archsurg.1986.01400110048008
Abstract
• The role of restaging laparotomy in the treatment of ovarian carcinoma is currently being reevaluated. This study was initiated to examine the predictive value of a negative outcome. Between November 1974 and October 1983, sixtythree patients with no clinical evidence of disease underwent 70 restaging laparotomies for ovarian carcinoma. The findings of 34 (49%) of these procedures were negative for residual disease. Patient follow-up ranged from 30 to 137 months. Twenty-eight patients are alive with no evidence of disease with a median follow-up of 62 months. Four patients have died of a second primary tumor. Only two patients had recurrence of their ovarian carcinoma following restaging laparotomy with negative findings (recurrence rate, 5.9%; 13.3% for patients with advanced disease). Patients with negative findings at restaging laparotomy have an excellent prognosis and a good chance of being cured of their disease. (Arch Surg 1986;121:1262-1264)Keywords
This publication has 3 references indexed in Scilit:
- Chemotherapy for advanced ovarian cancerCochrane Database of Systematic Reviews, 1999
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Adriamycin and the HeartNew England Journal of Medicine, 1979